Interim Management Statement
Introduction
I am pleased to present the Company's interim management statement for the
period from 1 October 2009 to 8 February 2010as required by the UK Listing
Authority's Disclosure and Transparency Rule 4.3.
Performance and dividends
The Company's approximate unaudited net asset value (NAV) as at 31 December
2009 was £26.5 million (30 September 2009: £26.3 million) or 87.6 pence per
share, excluding treasury shares (30 September 2009: 86.7 pence per share). The
net asset values for both 31 December 2009 and 30 September 2009 are after
accounting for the second revenue dividend for the year to 31 March 2010 of 1
penny per share (total cost: £303,059), paid on 6 January 2010 to shareholders
on the register as at 4 December 2009.
The net asset value has increased compared to the net asset value at 30
September 2009 as a result of an uplift in the unquoted investment valuations.
However, revenue return continues to be subdued in the face of lower yields on
cash deposits and liquid instruments.
The three month period to 31 December 2009 continues to be a difficult one for
the UK economy as a whole. Nevertheless, certain of the Company's investments
are showing a strong performance and the Company's high level of cash has
provided a strong degree of protection from the worst effects.
The Board is not aware of any significant events or transactions between 31
December 2009 and the date of this interim management statement which would have
a material impact on the net asset value of the Company.
Share buybacks
During the period from 1 October 2009 to 8 February 2010, the Company purchased
3,334 shares at an average price of 69 pence per share, to be held in treasury.
The current share price is 74 pence.
Portfolio
Further investments have been made during the period from 1 October 2009 to 8
February 2010:
+----------------------------------+------+------------------------------------+
|Name |£000's|  |
+----------------------------------+------+------------------------------------+
|Mirada Medical Limited |111 |Provider of medical imaging software|
+----------------------------------+------+------------------------------------+
|Mi-Pay Limited |57 |Outsourcer of payment processing |
| | |service to mobile network operators |
+----------------------------------+------+------------------------------------+
|Green Energy Property Services |14 |Energy performance certificate |
|Limited | |provider |
+----------------------------------+------+------------------------------------+
Disposals
During the period from 1 October 2009 to 8 February 2010, the Company disposed
of the Bank of America floating rate note (maturity 02/02/2011) for £1,968,000,
the Nationwide Building Society floating rate note (maturity 07/06/2010) for
£1,867,000, the Barclays Bank floating rate note (maturity 02/07/2010) for
£3,786,000 and the HBOS floating rate note (maturity 17/12/2009) for £450,000.
These disposals realised a capital profit of £101,000.
Top ten holdings (as at 31 December 2009)
+----------------------------------------------------------+-------------------+
|Investment |Carrying/fair value|
| |£000's |
+----------------------------------------------------------+-------------------+
|UBS floating rate note: maturity date 20 May 2011 |2,536 |
+----------------------------------------------------------+-------------------+
|Bank of Nova ScotiaFloating Rate Note: maturity date 22 |2,198 |
|September 2010 | |
+----------------------------------------------------------+-------------------+
|Geronimo Inns I VCT Limited |1,488 |
+----------------------------------------------------------+-------------------+
|Geronimo Inns II VCT Limited |1,488 |
+----------------------------------------------------------+-------------------+
|Bravo Inns II Limited |1,372 |
+----------------------------------------------------------+-------------------+
|Taunton Hospital Limited |1,000 |
+----------------------------------------------------------+-------------------+
|Forth Photonics Limited |555 |
+----------------------------------------------------------+-------------------+
|Mi-Pay Limited |522 |
+----------------------------------------------------------+-------------------+
|Prime Care Holdings Limited |483 |
+----------------------------------------------------------+-------------------+
|Dexela Limited |430 |
+----------------------------------------------------------+-------------------+
There have been no further significant events or transactions that the Board are
aware of which would have a material impact on the financial position of the
Company between 1 October 2009 and 8 February 2010.
Further information regarding historic and current financial performance and
other useful shareholder information can be found on the Fund's website
underwww.albion-ventures.co.uk <
http://www.albion-ventures.co.uk/>/Our
Funds/Albion Enterprise VCT PLC.
Maxwell Packe, Chairman
8 February 2010
For further information please contact:
Patrick Reeve, Albion Ventures LLP - tel: 020 7601 1850
[HUG#1381843]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.